Kestra Medical Technologies, Ltd.KMTS
Price (close)
$25.76
Market cap
$1.5B
P/E
—
Revenue (TTM)
$106.7M
Net income
-$149.9M
Dividend yield
—
1-year total return
6.8%
Net margin
-140.4%
Revenue growth
60.7%
Debt / equity
0.33x
What Kestra Medical Technologies, Ltd. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue | — | $27.8M | $59.8M | $95.1M |
| Net income | — | -$94.1M | -$113.8M | -$131.6M |
| Free cash flow | — | -$84.5M | -$100.5M | -$116.6M |
More on KMTS.
- Kestra Medical Technologies, Ltd. summary
- Kestra Medical Technologies, Ltd. financial statements
- Kestra Medical Technologies, Ltd. key metrics
- Kestra Medical Technologies, Ltd. health scores and style box
- Kestra Medical Technologies, Ltd. earnings
- Kestra Medical Technologies, Ltd. dividends
- Kestra Medical Technologies, Ltd. valuation
- Kestra Medical Technologies, Ltd. ownership and insiders
- Kestra Medical Technologies, Ltd. peers
Figures from Kestra Medical Technologies, Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.